FACTBOX-Key players in the animal health business

Related Topics

July 30 | Thu Jul 30, 2009 12:34pm EDT

July 30 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) expanded its animal health business by buying the other half of Merial from its U.S. partner Merck (MRK.N) for $4 billion in cash, while opening the door for a bigger partnership. [ID:nLU307753]

Here are some details about the key players in the animal health sector:

* BAYER BAYG.DE:

Segments -Companion Animals and Farm Animals

Key Products - Advantage, Baytril, Drontal

Sales 2008 - 963 million euros

* BOEHRINGER INGELHEIM:

Segments - Food Producing Animals - Cattle, Swine, Companion Animals - Small animals, Horse

Key Products - Ingelvac, Enterisol, Mamyzin, Metacam, Ubrolexin, Express, Vetmedin, Ventipulmin

Sales 2008 - 467 million euros

* MERIAL:

Segments - Dogs, Cats, Swine, Cows, Avian, Equine

Key Products - Frontline, Ivomec, Heartgard, Eqvalan, Gastrogard, Ulcergard and Purevax.

Sales 2008 - $2.6 billion

Employees - 5,400

* NOVARTIS (NOVN.VX):

Segments - Pet Health, Livestock and Bioprotection

Key Products - Denagard, Fortekor, Milbemax, Neporex , Interceptor, Agita, Prac-tic

Employees: 2593

Sales 2008 - $1.1 billion

* SCHERING-PLOUGH/INTERVET SGP.N:

Segments -Vaccines and Pharmaceuticals for companion animals, ruminants, equine, pigs and poultry

Key Products - Butox,Cobactan, Continum, Galaxy, Vista, Nuflor, Homeaain, Receptal

Sales 2008 - $2.9 billion

* PFIZER (PFE.N):

Segments - Livestock, Companion Animal and Horses

Key products - Bovi-Shield Gold, Convenia, Draxxin, Excede, Revolution, Rimadyl

Sales 2008 - $2.8 billion

* WYETH WYE.N/ Fort Dodge:

Segments: Livestock and companion animals

Key Products - ProMeris, ProHeart 6, West Nile-Innovator, the Duramune vaccine line, CYDECTIN Pour-on, the Pyramid vaccine line, Quest and Quest Plus

Revenue 2008 - $1.1 billion

Employees - 3500

Sources: Reuters/Company websites

(Writing by Carl Bagh, Bangalore Editorial Reference Unit; Editing by David Cutler; editing by Simon Jessop)

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.